Heteroaromatic isothiocyanates
US-2024124779-A1 · Apr 18, 2024 · US
US9828548B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9828548-B2 |
| Application number | US-201314405579-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 5, 2013 |
| Priority date | Jun 6, 2012 |
| Publication date | Nov 28, 2017 |
| Grant date | Nov 28, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
There is provided a liquid crystal composition which enables a significant reduction in crystallization temperature as compared with addition of a homolog while having a similar skeleton structure, which has an excellent compatibility, and which enables an increase in the absolute value of negative dielectric anisotropy (Δ∈). The liquid crystal composition contains two or more compounds which each have two to four ring structures between two side chains. At least one of the ring structures is a 2,3-difluorobenzene skeleton. The two side chains are bonded to different ring structures. The positions of the 2,3-difluorobenzene skeletons are different from each other, and the number of the ring structures are the same as each other.
Opening claim text (preview).
The invention claimed is: 1. A liquid crystal composition comprising two compounds, wherein said two compounds are: two selected from the group consisting of a compound represented by General Formula (I-1) and a compound represented by General Formula (I-2); or two selected from the group consisting of a compound represented by General Formula (II-1), a compound represented by General Formula (II-2), and a compound represented by General Formula (II-3); or two selected from the group consisting of a compound represented by General Formula (III-1), a compound represented by General Formula (III-2), a compound represented by General Formula (III-3), and a compound represented by General Formula (III-4), where R 111 to R 114 , R 121 to R 126 , and R 131 to R 138 each independently represent a linear or branched alkyl group having 1 to 18 carbon atoms, a hydrogen atom, or a fluorine atom; in the alkyl group, one —CH 2 — group or two or more —CH 2 — groups not adjoining each other are each optionally substituted with —O—, —S—, —CO—, —CO—O—, —O—CO—, —CO—S—, —S—CO—, —O—SO 2 —, —SO 2 —O—, —O—CO—O—, —CH═CH—, a cyclopropylene group, or —Si(CH 3 ) 2 —; at least one hydrogen atom of the alkyl group is optionally substituted with a fluorine atom, a chlorine atom, a bromine atom, or a CN group; Z 111 to Z 116 and Z 121 to Z 152 each independently represent —O—, —S—, —CO—, —CO—O—, —O—CO—, —O—CO—O—, —CO—N(R a )—, —N(R a )—CO—, —OCH 2 —, —CH 2 O—, —SCH 2 —, —CH 2 S—, —O—SO 2 —, —SO 2 —O—, —CF 2 O—, —OCF 2 —, —CF 2 S—, —SCF 2 —, —CH 2 CH 2 —, —CF 2 CH 2 —, —CH 2 CF 2 —, —CF 2 CF 2 —, —CH═CH—, —CF═CH—, —CH═CF—, —CF═CF—, —C≡C—, —CH═CH—CO—O—, —O—CO—CH═CH—, or a single bond; R a of —CO—N(R a )— or —N(R a )—CO— represents a hydrogen atom or a linear or branched alkyl group having 1 to 4 carbon atoms; A 111 , A 112 , A 121 , A 124 , A 125 , A 126 , and A 131 to A 142 each independently represent a cyclic group selected from a phenylene group, a cyclohexylene group, a dioxolanediyl group, a cyclohexenylene group, a bicyclo[2.2.2]octylene group, a piperidinediyl group, a naphthalenediyl group, a decahydronaphthalenediyl group, a tetrahydronaphthalenediyl group, and an indanediyl group; in the phenylene group, the naphthalenediyl group, the tetrahydronaphthalenediyl group, and the indanediyl group, at least one —CH═ group in each ring is optionally substituted with a nitrogen atom; in the cyclohexylene group, the dioxolanediyl group, the cyclohexenylene group, the bicyclo[2.2.2]octylene group, the piperidinediyl group, the decahydronaphthalenediyl group, the tetrahydronaphthalenediyl group, and the indanediyl group, one —CH 2 — group or two or more —CH 2 — groups not adjoining each other in each ring are optionally substituted with —O— and/or —S—; and at least one hydrogen atom of each cyclic group is optionally substituted with a fluorine atom, a chlorine atom, a bromine atom, a CN group, an NO 2 group, or an alkyl, alkoxy, alkylcarbonyl, or alkoxycarbonyl group which has 1 to 7 carbon atoms and of which one or more hydrogen atoms are each optionally substituted with a fluorine atom or a chlorine atom, wherein a compound in which A 111 , A 112 , A 121 , A 123 , A 124 , A 126 , and A 131 to A 142 are each a 2,3-difluorobenzene skeleton is excluded, and A 122 and A 123 are cyclohexylene group. 2. The liquid crystal composition according to claim 1 , wherein the liquid crystal composition exhibits a smectic liquid crystal phase. 3. The liquid crystal composition according to claim 1 , wherein the liquid crystal composition exhibits a nematic liquid crystal phase. 4. A liquid crystal display device comprising the liquid crystal composition according to claim 1 . 5. The liquid crystal composition according to claim 1 , wherein said two compounds are: the compound represented by General Formula (I-1) and the compound represented by General Formula (I-2); or the compound represented by General Formula (II-1) and the compound represented by General Formula (II-2); or the compound represented by General Formula (III-1) and the compound represented by General Formula (III-2). 6. The liquid crystal composition according to claim 1 , wherein said two compounds are the compound represented by General Formula (II-1) and the compound represented by General Formula (II-2). 7. The liquid crystal composition according to claim 1 , wherein said two compounds are the compound represented by General Formula (II-1) and the compound represented by General Formula (II-2), in which A 121 and A 124 are phenyl group. 8. The liquid crystal composition according to claim 6 , wherein the liquid crystal composition has a crystallization temperature of 2.8° C. or lower. 9. The liquid crystal composition according to claim 8 , wherein the liquid crystal composition has a crystallization temperature of less than 0° C. 10. The liquid crystal composition according to claim 7 , wherein the liquid crystal composition has a crystallization temperature of 2.8° C. or lower. 11. The liquid crystal composition according to claim 10 , wherein the liquid crystal composition has a crystallization temperature of less than 0° C.
in which at least two rings are linked by a carbon chain containing carbon to carbon single bonds · CPC title
Compounds containing at least two rings in which the different rings are directly linked (covalent bond) · CPC title
Heterocyclic compounds · CPC title
Cy-Cy-Ph · CPC title
at least two benzene rings directly linked, e.g. biphenyls · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.